Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for ThermoGenesis Holdings, Inc. (THMO : OTC)
 
 • Company Description   
ThermoGenesis Holdings Inc. develops, commercializes and markets automated technologies for CAR-T and other cell-based therapies. The company markets solutions for automated clinical biobanking, point-of-care applications and automation for immuno-oncology. ThermoGenesis Holdings Inc., formerly known as Cesca Therapeutics Inc., is based in Rancho Cordova, California.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.00 Daily Weekly Monthly
20 Day Moving Average: 794 shares
Shares Outstanding: 7.95 (millions)
Market Capitalization: $0.00 (millions)
Beta: 1.27
52 Week High: $0.02
52 Week Low: $0.00
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 0.00% -2.75%
12 Week 0.00% -6.66%
Year To Date % %
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2711 CITRUS ROAD
-
RANCHO CORDOVA,CA 95742
USA		 ph: 916-858-5100
fax: 916-858-5199		 ir@thermogenesis.com http://www.thermogenesis.com
 
 • General Corporate Information   
Officers
Chris Xu - Chief Executive Officer and Chairman
Jeffery Cauble - Chief Financial Officer
Russell Medford - Director
Joseph Thomis - Director
Biao Xi - Director

Peer Information
ThermoGenesis Holdings, Inc. (CORR.)
ThermoGenesis Holdings, Inc. (RSPI)
ThermoGenesis Holdings, Inc. (CGXP)
ThermoGenesis Holdings, Inc. (BGEN)
ThermoGenesis Holdings, Inc. (GTBP)
ThermoGenesis Holdings, Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 88362L209
SIC: 3821
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding: 7.95
Most Recent Split Date: 12.00 (0.02:1)
Beta: 1.27
Market Capitalization: $0.00 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
09/30/25 - -
06/30/25 - -
03/31/25 - -
ROA
09/30/25 - -
06/30/25 - -
03/31/25 - -
Current Ratio
09/30/25 - -
06/30/25 - -
03/31/25 - -
Quick Ratio
09/30/25 - -
06/30/25 - -
03/31/25 - -
Operating Margin
09/30/25 - -
06/30/25 - -
03/31/25 - -
Net Margin
09/30/25 - -
06/30/25 - -
03/31/25 - -
Pre-Tax Margin
09/30/25 - -
06/30/25 - -
03/31/25 - -
Book Value
09/30/25 - -
06/30/25 - -
03/31/25 - -
Inventory Turnover
09/30/25 - -
06/30/25 - -
03/31/25 - -
Debt-to-Equity
09/30/25 - -
06/30/25 - -
03/31/25 - -
Debt-to-Capital
09/30/25 - -
06/30/25 - -
03/31/25 - -
 

Powered by Zacks Investment Research ©